Search Press releases Keywords From To 6 Sep 2021 BIMZELX[®]▼ (bimekizumab) Receives First Positive Health Technology Assessment Worldwide Read More 3 Sep 2021 Transparency notification Wellington Read More 3 Sep 2021 Disposals of own shares Read More 27 Aug 2021 Disposals of own shares Read More 27 Aug 2021 UCB showcases commitment to treatment and management of epilepsy at the 34th International Epilepsy Congress Read More 24 Aug 2021 UCB Announces European Commission Approval of BIMZELX[®]▼ (bimekizumab) for the Treatment of Adults with Moderate to Severe Plaque Psoriasis Read More Pagination First page Previous page Previous … Page 53 Page 54 Page 55 Page 56 Current page 57 Page 58 Page 59 Page 60 Page 61 … Page 57 of 66 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
